Go Pro
→ Why the Treasury still prices gold at 42 dollars an ounce (From Golden Portfolio) (Ad)tc pixel Free PCVX Stock Alerts

Vaxcyte (PCVX) Short Interest Ratio & Short Volume

Vaxcyte logo
$59.47 +0.57 (+0.97%)
Closing price 09/11/2026 04:00 PM Eastern
Extended Trading
$57.73 -1.74 (-2.92%)
As of 09/11/2026 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Compare

Vaxcyte Short Interest Overview

As of August 31, 2026, Vaxcyte (PCVX) had a short interest of 15.02 million shares sold short, representing 10.44% of the public float. This marks a 1.49% increase in short interest since the prior report. The short interest ratio (days to cover) is 15.9, meaning it would take 15.9 days of the average trading volume of 942,360 shares to cover all short positions.

Current Short Interest
15,016,514 shares
Previous Short Interest
14,796,265 shares
Change Vs. Previous Month
1.49%
Dollar Volume Sold Short
$912.10 million
Short Interest Ratio
15.9 Days to Cover
Last Record Date
August 31, 2026
Outstanding Shares
148,805,000 shares
Short Percent of Float
10.44%
Today's Trading Volume
1,683,429 shares
Average Trading Volume
942,360 shares
Today's Volume Vs. Average
179%
Short Selling Vaxcyte?
A Guide To High-Short-Interest Stocks

Sign up to receive the latest short interest report for Vaxcyte and its competitors with MarketBeat's FREE newsletter.

Get Report
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Charts & View Short Interest History
Short Interest ChartDays to Cover ChartShort Percent of Float Chart

PCVX Short Interest Over Time

PCVX Days to Cover Over Time

PCVX Percentage of Float Shorted Over Time

Vaxcyte Tesla Short Interest History & Recent Changes

Export
Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
8/31/202615,016,514 shares $912.10 million +1.5%10.4%15.86 $60.74
8/14/202614,796,265 shares $859.22 million +2.3%10.3%15.85 $58.07
7/31/202614,464,951 shares $782.26 million +1.6%10.4%14.82 $54.08
7/15/202614,231,919 shares $807.52 million -18.5%10.2%12.37 $56.74
6/30/202617,468,070 shares $1.02 billion +19.4%12.5%6.91 $58.13
6/15/202614,629,103 shares $725.02 million +1.1%10.5%10.73 $49.56
5/29/202614,473,801 shares $743.95 million +5.0%10.4%8.85 $51.40
5/15/202613,789,778 shares $722.45 million -2.5%9.9%7.75 $52.39
4/30/202614,143,473 shares $809.57 million -1.5%10.1%13.09 $57.24
4/15/202614,356,548 shares $867.85 million +4.9%10.3%11.75 $60.45
3/31/202613,685,643 shares $795.27 million +4.7%9.8%9.77 $58.11
3/13/202613,067,798 shares $713.24 million -1.4%9.4%10.89 $54.58
2/27/202613,257,134 shares $818.50 million -3.6%9.5%10.72 $61.74
2/13/202613,755,621 shares $744.18 million +15.1%9.9%7.85 $54.10
1/30/202611,953,116 shares $640.33 million -1.2%9.4%7.51 $53.57
1/15/202612,095,806 shares $581.08 million +1.6%9.5%12.49 $48.04
12/31/202511,905,942 shares $549.34 million +10.0%9.4%9.81 $46.14
12/15/202510,827,314 shares $480.08 million +5.1%8.5%6.62 $44.34
11/28/202510,301,208 shares $511.35 million +10.3%8.1%7.67 $49.64
11/14/20259,336,796 shares $454.61 million +8.9%7.4%6.34 $48.69
10/31/20258,574,767 shares $388.27 million -14.4%6.8%6.57 $45.28
10/15/202510,010,000 shares $439.84 million -9.7%8.0%5.9 $43.94
9/30/202511,080,000 shares $399.10 million -2.5%N/A6.9 $36.02
9/15/202511,360,000 shares $352.16 million -1.3%N/A7.3 $31.00
8/31/202511,510,000 shares $354.39 million +0.6%9.1%8 $30.79
8/15/202511,440,000 shares $374.09 million -14.0%N/A7.5 $32.70
7/31/202513,300,000 shares $451.54 million -2.4%10.6%8.1 $33.95
7/15/202513,620,000 shares $480.51 million -3.2%N/A7.6 $35.28
6/30/202514,070,000 shares $457.42 million +2.7%11.3%6.7 $32.51
6/15/202513,700,000 shares $473.47 million +3.8%11.0%5.5 $34.56
5/31/202513,200,000 shares $430.32 million -2.2%10.9%5.4 $32.60
5/15/202513,490,000 shares $416.84 million +12.0%11.2%5.5 $30.90
4/30/202512,040,000 shares $431.51 million -2.4%N/A5.6 $35.84
4/15/202512,340,000 shares $373.04 million +2.4%10.2%6.3 $30.23
3/31/202512,050,000 shares $455.01 million -4.4%10.0%6.6 $37.76
3/15/202512,610,000 shares $937.81 million +2.3%10.4%10.9 $74.37
2/28/202512,330,000 shares $900.34 million -7.5%10.2%10.7 $73.02
2/15/202513,330,000 shares $1.12 billion -1.5%11.0%12 $84.00
1/31/202513,530,000 shares $1.19 billion -6.6%N/A10.3 $88.32
1/15/202514,490,000 shares $1.29 billion +1.2%N/A11.4 $89.29
Three companies about to leapfrog Nvidia [And transform the entire industry] (Ad)

Three under-the-radar companies are already building the infrastructure behind a 200 billion government-backed tech push, according to analyst George Gilder. Gilder calls it the Trillion Dollar Triangle, technology he says makes today's AI infrastructure look outdated. All three companies are already moving, not just planned.tc pixel

See George Gilder's full Trillion Dollar Triangle briefing now
12/31/202414,320,000 shares $1.17 billion +13.7%N/A12.7 $81.86
12/15/202412,600,000 shares $1.11 billion +14.2%N/A11.4 $87.72
11/30/202411,030,000 shares $1.04 billion +13.8%N/A10.4 $94.34
11/15/20249,690,000 shares $841.38 million +8.5%N/A7.6 $86.83
10/31/20248,930,000 shares $949.71 million -4.4%N/A9.2 $106.35
10/15/20249,340,000 shares $1.08 billion -3.2%N/A10.2 $115.49
9/30/20249,650,000 shares $1.10 billion -0.6%N/A10 $114.27
9/15/20249,710,000 shares $1.13 billion -5.7%N/A9.4 $116.00
8/31/202410,300,000 shares $831.83 million -8.4%N/A10.4 $80.76
8/15/202411,240,000 shares $881.67 million -2.3%N/A15.9 $78.44
7/31/202411,500,000 shares $907.24 million -3.1%N/A15.4 $78.89
7/15/202411,870,000 shares $999.10 million +15.5%N/A16.2 $84.17
6/30/202410,280,000 shares $776.24 million +6.2%N/A14.6 $75.51
6/15/20249,680,500 shares $706.10 million +0.8%N/A14.9 $72.94
5/31/20249,600,000 shares $674.59 million +0.8%N/A15.3 $70.27
5/15/20249,520,000 shares $681.92 million +12.9%N/A13.7 $71.63
4/30/20248,430,000 shares $510.44 million +2.3%N/A11.7 $60.55
4/15/20248,240,000 shares $514.09 million -0.2%N/A9.7 $62.39
3/31/20248,260,000 shares $564.24 million -3.8%N/A9.6 $68.31
3/15/20248,590,000 shares $598.72 million +1.5%N/A9.9 $69.70
2/29/20248,460,000 shares $624.52 million -20.6%N/A9.3 $73.82
2/15/202410,650,000 shares $798.86 million +19.7%N/A12.3 $75.01
1/31/20248,900,000 shares $635.64 million +6.5%N/A10.7 $71.42
1/15/20248,360,000 shares $507.62 million +9.7%N/A12.4 $60.72
12/31/20237,620,000 shares $478.54 million +3.7%N/A11.6 $62.80
12/15/20237,350,000 shares $445.12 million +3.8%N/A11.6 $60.56
11/30/20237,080,000 shares $366.53 million -2.6%N/A11.5 $51.77
11/15/20237,270,000 shares $369.32 million -0.8%N/A12.6 $50.80
10/31/20237,330,000 shares $352.57 million +6.2%N/A12.7 $48.10
10/15/20236,900,000 shares $317.40 million -4.2%N/A12.8 $46.00
9/30/20237,200,000 shares $367.06 million -9.1%N/A13.5 $50.98
9/15/20237,920,000 shares $409.62 million +4.9%N/A14.9 $51.72
8/31/20237,550,000 shares $392.00 million -2.6%N/A13.9 $51.92
8/15/20237,750,000 shares $368.05 million +3.6%N/A13.6 $47.49
7/31/20237,480,000 shares $359.49 million -0.1%N/A12.3 $48.06
7/15/20237,490,000 shares $371.80 million +0.4%N/A10.2 $49.64
6/30/20237,460,000 shares $372.55 million +8.4%N/A8.1 $49.94
6/15/20236,880,000 shares $358.72 million -2.7%N/A7.2 $52.14
5/31/20237,070,000 shares $350.11 million +4.0%N/A7.5 $49.52
5/15/20236,800,000 shares $342.45 million +3.8%N/A7 $50.36
4/30/20236,550,000 shares $280.54 million -7.1%N/A7 $42.83
4/15/20237,050,000 shares $257.33 million +17.3%N/A8.1 $36.50
3/31/20236,010,000 shares $225.25 million +6.0%N/A8.8 $37.48
3/15/20235,670,000 shares $220.56 million +14.8%N/A8.3 $38.90
2/28/20234,940,000 shares $202.39 million +4.7%N/A7 $40.97
2/15/20234,720,000 shares $203.67 million +1.5%N/A6.6 $43.15
1/31/20234,650,000 shares $210.88 million +5.9%N/A6 $45.35
1/15/20234,390,000 shares $195.88 million -2.0%N/A3.3 $44.62
12/30/20224,480,000 shares $214.82 million +30.2%N/A3.4 $47.95
12/15/20223,440,000 shares $156.45 million +3.6%N/A2.6 $45.48
Shocking AI prediction from the “Billionaire Whisperer" (Ad)

Marc Chaikin's Power Gauge system flagged Micron before it soared 970 percent, Celestica before a 6,600 percent run, and Nvidia before it climbed more than 50,000 percent. Now Chaikin says a new AI data center technology using 99 percent less electricity, water, and space could accelerate scientific breakthroughs 360-fold, and one company behind it just flashed bullish in his system. See the full research and the ticker Chaikin is watching before this presentation goes offline.tc pixel

Watch Chaikin's free presentation and see the ticker now
11/30/20223,320,000 shares $152.92 million -8.8%N/A2.7 $46.06
11/15/20223,640,000 shares $160.31 million -12.3%N/A3.1 $44.04
10/31/20224,150,000 shares $180.98 million +29.7%N/A3.7 $43.61
10/15/20223,200,000 shares $78.59 million +29.0%8.2%4.2 $24.56
9/30/20222,480,000 shares $59.52 million +22.8%6.3%5.7 $24.00
9/15/20222,020,000 shares $57.00 million +10.4%5.2%5.1 $28.22
8/31/20221,830,000 shares $47.87 million -12.9%4.7%4.8 $26.16
8/15/20222,100,000 shares $54.68 million +4.5%5.4%5.5 $26.04
7/31/20222,010,000 shares $46.39 million -1.0%5.3%5.4 $23.08
7/15/20222,030,000 shares $50.53 million +9.7%5.4%5.6 $24.89
6/30/20221,850,000 shares $40.26 million +11.5%4.9%5 $21.76
6/15/20221,660,000 shares $31.04 million -18.2%4.4%4.4 $18.70
5/31/20222,030,000 shares $48.70 million +2.0%5.4%6.3 $23.99
5/15/20221,990,000 shares $46.82 million +4.2%5.3%7 $23.53
4/30/20221,910,000 shares $46.24 million +2.7%5.2%6.9 $24.21
4/15/20221,860,000 shares $45.63 million -6.5%5.0%6.6 $24.53
3/31/20221,990,000 shares $48.06 million -0.5%5.6%6.3 $24.15
3/15/20222,000,000 shares $49.78 million -1.5%5.6%6.9 $24.89
2/28/20222,030,000 shares $47.04 million +9.7%5.7%7 $23.17
2/15/20221,850,000 shares $38.31 million +12.8%5.3%6.4 $20.71
1/31/20221,640,000 shares $31.23 million +28.1%5.1%6.2 $19.04
1/15/20221,280,000 shares $24.87 million +14.3%4.0%5.5 $19.43
12/31/20211,120,000 shares $26.64 million -21.7%3.7%7 $23.79
12/15/20211,430,000 shares $32.02 million +26.6%4.7%9.5 $22.39
11/30/20211,130,000 shares $23.03 million -7.4%3.8%7.5 $20.38
11/15/20211,220,000 shares $31.82 million -6.9%4.1%8.1 $26.08
10/29/20211,310,000 shares $30.65 million +2.3%4.5%8 $23.40
10/15/20211,280,000 shares $31.24 million -9.9%4.3%7.8 $24.41
9/30/20211,420,000 shares $36.03 million -20.7%4.8%8.4 $25.37
9/15/20211,790,000 shares $47.35 million -23.5%6.1%9 $26.45

PCVX Short Interest - Frequently Asked Questions

Short interest is the volume of Vaxcyte shares that have been sold short but have not yet been covered or closed out. As of August 31st, investors have sold 15,016,514 shares of PCVX short. 10.44% of Vaxcyte's shares are currently sold short. Learn More on Vaxcyte's current short interest.

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. PCVX shares currently have a short interest ratio of 15.9. Learn More on Vaxcyte's short interest ratio.

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 10.44% of Vaxcyte's floating shares are currently sold short.

Vaxcyte saw a increase in short interest in the month of August. As of August 31st, there was short interest totaling 15,016,514 shares, an increase of 1.5% from the previous total of 14,796,265 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

10.44% of Vaxcyte's shares are currently sold short. Here is how the short interest of companies in the industry of "biotechnology" compare to Vaxcyte: Alnylam Pharmaceuticals, Inc. (4.78%), Biogen Inc. (3.89%), Insmed, Inc. (5.35%), BioNTech SE Sponsored ADR (1.13%), Incyte Corporation (5.51%), Roivant Sciences Ltd. (5.09%), Genmab A/S Sponsored ADR (1.11%), United Therapeutics Corporation (5.25%), Ascendis Pharma A/S (11.23%), BridgeBio Pharma, Inc. (13.03%),

As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($62.68 billion), Invesco QQQ ($47.06 billion), iShares Russell 2000 ETF ($23.54 billion), SPDR S&P Biotech ETF ($12.10 billion), Nebius Group N.V. ($9.34 billion), Western Digital Corporation ($8.96 billion), Financial Select Sector SPDR Fund ($8.16 billion), iShares 20+ Year Treasury Bond ETF ($7.98 billion), iShares iBoxx $ High Yield Corporate Bond ETF ($7.52 billion), and VanEck Semiconductor ETF ($7.39 billion). View all of the most shorted stocks.

Short selling PCVX is an investing strategy that aims to generate trading profit from Vaxcyte as its price is falling. PCVX shares are trading up $0.57 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Vaxcyte occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of PCVX, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including PCVX, twice per month. The most recent reporting period available is August, 31 2026.

Understanding short interest metrics can help you assess how traders are positioning around a stock like PCVX:

  • Shares Sold Short: The total number of shares that have been sold by short sellers but have not yet been covered or closed out. A high number may indicate bearish sentiment.
  • Short Float: The percentage of a company’s publicly available shares (or "float") that are sold short. A higher short float suggests a greater portion of the stock is being bet against.
  • Days to Cover (Short Interest Ratio): This estimates how many days it would take short sellers to cover their positions, based on average daily trading volume. Higher values can signal potential for a short squeeze if buying pressure increases.

These metrics are often used by traders to gauge sentiment, volatility risk, and the potential for price movements based on short covering activity.


Related Companies
Short Interest Tools

Short interest data for NASDAQ:PCVX is sourced from the Financial Industry Regulatory Authority (FINRA), with the most recent report published on 9/10/2026. FINRA publishes updated short interest twice a month.
From Our Partners
Why I'm NOT Buying the SpaceX IPO (And What I'm Buying Instead)
Don't buy Nvidia... Not when the AI companies that will define the next decade are selling for pennies. You wo...
Decentralized Masters | Sponsoredtc pixel
Elon Musk to Trigger Next AI Wave on November 11th?
Jeff Brown picked Nvidia in 2016, before shares surged 37,800 percent. Now he's identified another AI company ...
Brownstone Research | Sponsoredtc pixel
Here’s the stock symbol I’ve promised
Whitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...
Stansberry Research | Sponsoredtc pixel
What Is A Roth Conversion, And How Do I Set One Up?
A Roth conversion moves money from a traditional IRA or employer plan into a Roth IRA, triggering income tax t...
SmartAsset | Sponsoredtc pixel
This 38 Dollar Fund Holds Every Major AI Stock and Pays Weekly
The biggest AI stocks like Nvidia, CrowdStrike, and Palantir now trade for hundreds of dollars a share. One fu...
Investors Alley | Sponsoredtc pixel
Elon Musk’s Hushed FCC Filing. Sept 25th.
Elon Musk quietly filed a document with the federal government tied to artificial intelligence, one of the lar...
Paradigm Press | Sponsoredtc pixel
The retirement stock I'd buy before Nvidia today
In 2014, Marc Chaikin pointed readers toward Nvidia. Now the 60-year Wall Street veteran and creator of the Ch...
Chaikin Analytics | Sponsoredtc pixel
Musk says UBI is coming. I say it's already here.
Elon Musk says AI could make money irrelevant by 2036. One income program already exists today, funded not by ...
Freedom Financial | Sponsoredtc pixel